pennews
www.pennews.net
Sun Pharma moves up after agreement on selling generic drugs in China
Business

Sun Pharma moves up after agreement on selling generic drugs in China

Agency News

Sun Pharma has entered into an agreement with China Medical System Holdings to develop and commercialize seven generic products in Mainland China. Shares of Sun Pharma has gone up as much as 4.69 per cent in the morning hours after the company signed a licensing agreement with China Medical System Holdings for generic products in Mainland China. On the National Stock Exchange, Sun Pharma share hit at Rs. 434.20 compared with its Friday's closing price of Rs.414.70.

One of the subsidiaries of Sun Pharma has entered into an agreement with China Medical System Holdings to develop and commercialize seven generic products in Mainland China. "This collaboration gives us entry into the Chinese generic pharmaceutical market. We see lot of potential in China for both, our generics and speciality portfolio.," an NDTV report quoted Dilip Shanghvi, managing director, Sun Pharma as saying.